TNFRSF17 and cancer: In data from two independent donors, the anti-BCMA BAFF-R CAR showed significantly improved control of MM1S cancer compared to 4-1BB (p = 0.017; t-test based on the normalized total cancer radiance AUC) (Fig. 7C).